Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

Also called NCT03601039

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 165 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03601039
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03601039. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08-25 (actual); primary completion 2020-08-28 (actual). Results posted on 2026-03-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients
Condition
Heart Septal Defects, Atrial
Condition
Atrial Septal Defect
Intervention (Device)
Absnow Absorbable ASD Closure System
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03601039
Content hash
0446be557f79817cdb44f987461f302df8ab3887e95c8a83c47b91f443bd5cfa